ABBOTT DIAGNOSTICS TECHNOLOGIES AS
- Shared products
- ALBUMIN, C-REACTIVE PROTEIN, COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins, Instrument intended for immunoassays, PARÂMETROS COMBINADOS NO MESMO PRODUTO - CLASSE II
- Shared products
- ALBUMIN, C-REACTIVE PROTEIN, COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins, Instrument intended for immunoassays
- Shared products
- ALBUMIN, C-REACTIVE PROTEIN, COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins, Instrument intended for immunoassays
- Shared products
- ALBUMIN, C-REACTIVE PROTEIN, COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins, Instrument intended for immunoassays
- Shared products
- ALBUMIN, C-REACTIVE PROTEIN, COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins, Instrument intended for immunoassays
Explore comprehensive manufacturer profile for ABBOTT DIAGNOSTICS TECHNOLOGIES AS based in Norway through Pure Global AI's free Brazil medical device database. This manufacturer has 14 products registered with ANVISA across 6 unique technical categories. Their regulatory history spans from Feb 17, 2014 to Mar 05, 2018.
This page provides detailed insights including 5 recent product registrations including Instrument intended for immunoassays, 5 most popular products with GLYCATED HEMOGLOBIN (HbA1C) having 4 registrations, 1 registration holders including ABBOTT DIAGNOSTICOS RAPIDOS S.A., and 5 key competitors with ZYBIO INC. sharing 7 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.